SUMMARY Roughly 5% of all patients with retinoblastoma carry a constitutional chromosome deletion on the long arm of chromosome 13, which confers a prezygotic predisposition to tumour development. As for 20 minutes and the cells harvested and treated with 0-07M potassium chloride for 10 minutes. Lymphocytes were then fixed in three changes of 3:1 methanol:acetic acid, and chromosome preparations were made using standard air drying techniques. Subsequent chromosome banding was performed by the modified trypsin-Giemsa method described by Cowell.6 Enzyme analysis. Esterase D activities were measured in red blood cells essentially as described elsewhere.2 The hydrolysis of 4-methylumbelliferyl acetate to 4-methylumbelliferone was followed fluorimetrically. Washed red cells were lysed by freezing/thawing and 10
are both sporadic and hereditary forms. In the United Kingdom about 20-24% of cases are familial.2 In about 5% of patients a prezygotic predisposition to tumour formation is associated with a somatic deletion, of variable length, from the long arm of one copy of chromosome 13.1 3 When the deletion is large there are usually associated congenital abnormalities, including severe mental retardation, and the patients do not reproduce. In patients with small deletions, however, the associated abnormalities may be less severe or absent4 and offspring have roughly a 50% chance of inheriting the deletion and also developing the tumour.
Esterase D is found in most human tissues, but its function is unknown. The gene for esterase D has been localised to region 13q145 and patients with retinoblastoma carrying a deletion have 50% esterase D activity in their cells. Psychomotor development was initially thought to be slow, but at 2 years the development quotient was 94. At 3 years the child was able to speak in sentences and was thought to be developing within the normal range.
Macrocephaly persisted from birth (at 3 years head circumference was 54-7 cm, which is above the 97th centile), while height and weight were still at the 50th centile. The head growth, however, remained parallel to the 97th centile from birth. There were no other dysmorphic features. An Indian male infant, the third child of healthy parents, was found to have several raised red patches on both arms, right thigh, and left cheek immediately after a normal birth at home. Over the next three days these lesions became dark blue in colour, increased in size, and blistered in the centre. After admission to hospital new lesions appeared and merged into one another, more bullae developed, and in some areas such as the buttocks the skin became thickened, hard, and necrotic. On the fourth day of life the left lower limb was cold and indurated. It was purple in colour with a demarcation line above the ankle. No peripheral pulses were palpable. In spite of treatment with vitamin K and infusions of fibrinogen and fresh whole blood the infant's condition deteriorated with bleeding from nose and gums, the passage of tarry stools, and distension of the abdomen. The positive laboratory findings included lowered plasma fibrinogen, thrombocytopenia, and haemoglobin concentration down to 5-6 gldl. Clot retraction was abnormal. Death occurred on the eighth day. At autopsy widespread thrombosis was found in veins, capillaries, and arterioles. There was extravasation of blood in the subcutaneous fat, large intestine, bladder, and perinephric fat. All the intracranial venous sinuses were thrombosed. The author concluded that this disorder was essentially one of intravascular thrombosis. As the first child of the parents had died aged 9 days of a very similar illness the possibility of a genetically determined hereditary disorder was considered. From estimations of plasma fibrinogen concentrations in both parents (less than 40% of the mean) Van Der Horst suggested the presence of a congenital deficiency of fibrinogen in this family, although he seemed to consider that the cause of the purpura fulminans was more probably related to Shwartzman's phenomenon.
Comment. This was the first recorded case of purpura fulminans in a newborn infant. Several recent case reports have indicated, however, that the disease is a manifestation of disseminated intravascular coagulation and due to congenital absence of plasma protein C, which is one of the vitamin K dependent serine proteases. In its activated form it is a potential anticoagulant as well as a profibrinolytic agent. The disease is inherited as an autosomal recessive. Affected infants have prptein C concentrations at zero, while in the heterozygous parents concentrations have been reported to be under 50% of normal. The cases so far reported have all ended fatally save for one Chinese infant in whom cryoprecipitate and fresh frozen plasma induced a remission that was successfully maintained by the administration of warfarin. ' It is important to recognise purpura fulminans in the newborn as a distinct entity, quite separate from the cases of fulminating or necrotic purpura that have been reported in older children. J H HUTCHISON 
